Emerg Infect Dis by Chalker, Victoria J. et al.
 Page 1 of 5 
Article DOI: http://dx.doi.org/10.3201/eid2206.142050 
Integration of Genomic and Other 
Epidemiologic Data to Investigate and 
Control Cross-Institutional Streptococcus 
pyogenes Outbreak 
Technical Appendix 
Full Literature Review Results  
Seventy-two iGAS outbreaks in LTCFs were identified, from individual outbreak 
reports (1–14) or summary data identified in surveillance studies or reviews (6,13,15–20), or 
laboratory studies (16). These 72 include 31 clusters defined as outbreaks based on shared 
subtypes among 2 or more cases occurring at a facility within 1 year (15,18). One of these 
found 13 clusters which shared sub-type, institution and time period among 134 cases, and 
eight instances of two isolates from the same time period and institution but with 
distinguishable subtypes which did not meet their subtype based outbreak definition. Among 
outbreaks identified by other means 22 reported subtyping. Nineteen of these identified a 
single or dominant strain (1,3,5–13,16), and three multiple strains (2,4,14). 
Treatment restricted to those ill or to cases and direct contacts of cases with laboratory 
confirmed infection was associated with control in some outbreaks (5,7,13), although in one 
mass chemoprophylaxis was applied following recurrence after two rounds of this selective 
treatment (1). Screening all staff and residents with chemoprophylaxis if positive (2–
4,6,8,9,11–14) was associated with recurrence and repeated screening and treatment in two 
reports (2,8). Further cases of iGAS were diagnosed between decisions to screen and 
chemoprophylax and the implementation of chemoprophylaxis (1,11). Mass 
chemoprophylaxis of all staff and residents was associated with control of iGAS (1,3,10,13) 
although in one incident persistent infection was shown in one resident with a gastrostomy 
tube (1). Screening detected carriage rates were below 10% among residents with two 
exceptions (20% (5) and 16% (11)) with lower rates among staff than residents as reviewed 
elsewhere (6,13). 
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Technical Appendix Table. Genes of interest, presence and absence 
Gene name Accession no. used for comparison Protein and Function 
Presence/absence in 
study isolates 
Capsule    
 HasA  Hyaluronase, production of 
hyaluronic acid capsule 
+ 
 HasB  Production of hyaluronic acid 
capsule 
+ 
 HasC  Production of hyaluronic acid 
capsule 
+ 
 PrtS  Cell envelope proteinase + 
 Phage    
 AbiR  Abortive infection phage resistance 
protein 
+ 
 MF4  Mitogenic factor - phage associated – (except ERR027369 +) 
 Spd3  DNase (Similar to mitogenic factor), 
phage associated) 
+ (except ERR027369 –) 
 Spy1438  Phage associated cell wall 
hydrolase 
+ (except ERR027369 –) 
 SpyM3–1302 SpyM3_1302, 
gi|21909536:c1315318–1314461 
Streptococcus pyogenes MGAS315 
chromosome, complete genome 
Phage protein – 
Regulatory proteins    
 CcpA  Regulatory protein + 
 CovR gb|EU726239.1|:241–927 S. 
pyogenes  strain H342 CovR 
Two-component regulation + 
 CovS gb|EU726239.1|:933–2435 S. 
pyogenes  strain H342 CovS 
Two-component regulation + 
 MsmR gb|DQ984656.1|:6744–7949 S. 
pyogenes  strain ALAB49 MsmR 
Operon regulatory protein, msm – 
 MtsR  Transcriptional regulator of metal 
ABC transporter MtsR-like 
Metalloregulator – manganese 
+ 
 Nra gb|DQ984656.1|:126–1661 S. 
pyogenes  strain ALAB49 Nra 
Negative transcriptional regulator 
 
– 
 PerR  Ferric uptake regulation protein + 
 Rgg  Rgg regulator, production of SpeB 
Cysteine protease 
+ 
 RopB  Rgg regulator, production of SpeB 
Cysteine protease 
+ 
Attachment    
 Cpa gb|DQ984656.1|:2092–3675 S. 
pyogenes  strain ALAB49 Cpa 
Fimbrial minor sturctural protein 
Cpa/FctA 
– 
 FctA gb|DQ984656.1|:4211–5158 S. 
pyogenes  strain ALAB49 FctA 
Fimbrial minor sturctural protein 
Cpa/FctA 
– 
 FctB gb|DQ984656.1|:6014–6583 S. 
pyogenes  strain ALAB49 Nra FctB 
Fimbrial minor structural protein – 
Toxins/pathogenicity 
factors 
   
 ABC-transporter gb|AF227521.1|:4607–6070 ABC-transporter – 
 Emm1  M protein + 
 EndoS  Endoglycoside, immunoglobulin 
degrading enzyme 
+ 
 Fba  Fructose-bisphosphate aldolase + 
 GRAB  G protein-related a2-macroglobulin 
binding protein 
+ 
 IdeS  Immunoglobulin G endopeptidase, 
CD11b homologue 
– 
 LaCD  Tagatose 1,6-diphosphate aldolase + 
 Mac  Immunoglobulin G-endopeptidase 
(IdeS) 
– 
 PrtF2 gb|DQ984656.1|:8334–10535 S. 
pyogenes  strain ALAB49 PrtF2 
Fibrinonectin binding protein – 
 SagA  Streptolysin S precursor + 
 SagB  Streptolysin S production + 
 SagC  Streptolysin S production + 
 Scl1  Collagen-like surface protein – 
 Scl2  Collagen-like surface protein – 
 ScpA  C5a peptidase + 
 Sda1  Extracellular streptodornase S, 
DNase 
+ 
 SpeA  Exotoxin A superantigen + 
 SpeB  Streptococcal pyrogenic exotoxin B, 
cysteine protease 
+ 
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Gene name Accession no. used for comparison Protein and Function 
Presence/absence in 
study isolates 
 SpeC  Exotoxin C – (except H130620574, 
H130620575 +) 
 SpeJ  Exotoxin J + 
 Sic  Streptococcal inhibitor of 
complement 
+ 
 Ska  Streptokinase – 
 Slo  Streptolysin O + 
 Sof  Serum opacity factor – 
 Spd  DNase + 
 SpeG  Pyrogenic exotoxin + 
 Spy1063  Iron(III) binding protein + 
 Spy1064  Unknown + 
 Spy1066  Hydrolase (HAD superfamily) + 
 Spy1065  O-Acetyltranseferase (cell wall 
biosynthesis) 
+ 
 SpyCEP gi|94989509:345557–351976 S. 
pyogenes  MGAS10270 
chromosome, complete genome 
Interleukin-8 protease, cell 
envelope protein 
– 
 SpyA gi|71909814:c358588–357610 S. 
pyogenes  MGAS5005 
chromosome, complete genome 
C3 family ADP-ribosyltransferase + 
 SrtC2 gb|DQ984656.1|:5254–5979 S. 
pyogenes  strain ALAB49 SrtC2 
Sortase – 
 UmuC-MucB gb|AF227521.1|:6839–8128 Lesion-replicating DNA 
polymerases 
– 
Antimicrobial resistance    
 FbaA  Fibrinonectin binding protein + 
 GyrA  Fluoroquinalone resistance + 
 Mef  Macrolide resistance – 
 MefA gb|AF227521.1|:3270–4487 Macrolide resistance macrolide-
efflux protein A (mefA) 
– 
 MefMB56Spyo029  Macrolide resistance – 
 MefV1  Macrolide resistance – 
 MefV2  Macrolide resistance – 
 MefV3  Macrolide resistance – 
 Nga  NAD glycohydrolase + 
 ParC  Fluoroquinalone resistance + 
 TetM  Tetracycline resistance – 
 TetO  Tetracycline resistance – 
 
 
 
